Skip to main content

Medicines labeled for the same conditions

Alternatives to oatmeal

6 other medicines are given the same way (topical) and in the same FDA class as oatmeal or labeled mainly for the same use (eczema (atopic dermatitis)); the others include 2 phosphodiesterase 4 inhibitors, 2 janus kinase inhibitors and 1 corticosteroid (FDA labels read October 8, 2026).

Which medicines are labeled for the same conditions as oatmeal?

Eczema (atopic dermatitis) lists all 26 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.

Medicine and FDA classShared indicationGeneric labelers (topical)Pharmacy costBoxed warningShortage
Oatmealthis medicinenone listedn/aNoNo current entry
DesonidecorticosteroidEczema (atopic dermatitis)12 labelers$0.252 per gram 0.05% creamNoNo current entry
Pimecrolimuscalcineurin inhibitor immunosuppressantEczema (atopic dermatitis)2 labelers$3.31 per gram 1% creamYesNo current entry
Crisaborolephosphodiesterase 4 inhibitorEczema (atopic dermatitis)none listed$11.68 per gram 2% ointmentNoNo current entry
Delgocitinibjanus kinase inhibitorEczema (atopic dermatitis)none listedn/aNoNo current entry
Difamilastphosphodiesterase 4 inhibitorEczema (atopic dermatitis)none listedn/aNoNo current entry
Ruxolitinibjanus kinase inhibitorEczema (atopic dermatitis)none listed$34.01 per gram 1.5% creamNoNo current entry

Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)

What do pharmacies pay for each?

The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?

Oatmeal: the full record
label, generics, price, shortages, recalls